Busetti, A., Thompson, T.P., Tegazzini, D., Megaw, J., Maggs, C. and Gilmore, B.F., 2015. Antibiofilm Activity of the Brown Alga Halidrys siliquosa against Clinically Relevant Human Pathogens. Marine Drugs, 13 (6), 3581 - 3605.
Full text available as:
|
PDF (OPEN ACCESS ARTICLE)
Antibiofilm Activity of the Brown Alga Halidrys siliquosa against Clinically Relevant Human Pathogens.pdf - Published Version Available under License Creative Commons Attribution. 2MB | |
Copyright to original material in this document is with the original owner(s). Access to this content through BURO is granted on condition that you use it only for research, scholarly or other non-commercial purposes. If you wish to use it for any other purposes, you must contact BU via BURO@bournemouth.ac.uk. Any third party copyright material in this document remains the property of its respective owner(s). BU grants no licence for further use of that third party material. |
DOI: 10.3390/md13063581
Abstract
The marine brown alga Halidrys siliquosa is known to produce compounds with antifouling activity against several marine bacteria. The aim of this study was to evaluate the antimicrobial and antibiofilm activity of organic extracts obtained from the marine brown alga H. siliquosa against a focused panel of clinically relevant human pathogens commonly associated with biofilm-related infections. The partially fractionated methanolic extract obtained from H. siliquosa collected along the shores of Co. Donegal; Ireland; displayed antimicrobial activity against bacteria of the genus Staphylococcus; Streptococcus; Enterococcus; Pseudomonas; Stenotrophomonas; and Chromobacterium with MIC and MBC values ranging from 0.0391 to 5 mg/mL. Biofilms of S. aureus MRSA were found to be susceptible to the algal methanolic extract with MBEC values ranging from 1.25 mg/mL to 5 mg/mL respectively. Confocal laser scanning microscopy using LIVE/DEAD staining confirmed the antimicrobial nature of the antibiofilm activity observed using the MBEC assay. A bioassay-guided fractionation method was developed yielding 10 active fractions from which to perform purification and structural elucidation of clinically-relevant antibiofilm compounds.
Item Type: | Article |
---|---|
ISSN: | 1660-3397 |
Uncontrolled Keywords: | Halidrys siliquosa ; antibiofilm ; antimicrobial ; biodiscovery ; clinical strains ; extraction ; Anti-Bacterial Agents ; Bacteria ; Biofilms ; Humans ; Ireland ; Microbial Sensitivity Tests ; Microscopy, Confocal ; Phaeophyta |
Group: | Faculty of Science & Technology |
ID Code: | 24477 |
Deposited By: | Symplectic RT2 |
Deposited On: | 08 Aug 2016 14:58 |
Last Modified: | 14 Mar 2022 13:57 |
Downloads
Downloads per month over past year
Repository Staff Only - |